Blood Test for Alzheimer's Predicts Future Cognitive Decline

BREAKTHROUGH: Researchers have developed a blood test that can predict the risk of future cognitive decline and Alzheimer's. The test checks levels of a fragment of the protein tau, a hallmark of AD. Find out more.

Read more »

Blood Test Finally Available to Diagnose Alzheimer's

DIAGNOSIS: A highly sensitive blood test has reached the market that can identify whether it is likely a patient has amyloid plaques in the brain, or not. Amyloid plaques are among the strongest pathological hallmarks of Alzheimer’s. Learn more.

Read more »

A Big Step in Treating Wandering in Dementia

Wandering is a common and often dangerous symptom to contend with. 60% of people with dementia wander off at some point. Although it has long been a mystery, Japanese researchers have tracked down the cause of this behavior. Find out more.

Read more »

PrecivityAD™ Blood Test Helps Diagnose Alzheimer's

BREAKTHROUGH & DIAGNOSIS: Research shows that a blood test now on the market accurately identifies brain amyloid status with a single blood sample. In other words, this blood test can diagnose Alzheimer's. Find out more.

Read more »

Today's Sleep Patterns Predict, Prevent Tomorrow's Alzheimer's

NEUROSCIENTISTS have discovered they can estimate when Alzheimer's is most likely to strike a person, based on his or her sleep pattern. The best defense: plenty of deep, restorative sleep. And there's more.

Read more »

FDA Approves Aduhelm, New Alzheimer's Drug

BREAKTHROUGH:

FOR THE FIRST TIME in 18 years, the FDA approved a new Alzheimer's drug. The new medication's generic name is aducanumab and will be marketed under the brand name Aduhelm. Another first is the drug's ability to potentially slow down Alzheimer's, not just cover up its symptoms, as existing medications do. Find out more.

Read more »

New Alzheimer's Drug Expediting FDA Trials

BREAKTHROUGH: The US Food and Drug Administration (FDA) has granted a "Breakthrough Therapy" designation for donanemab, a potential new treatment for people with early symptomatic Alzheimer's. Find out more.

Read more »

Why 20+ Years to Approve a New Alzheimer's Drug?

BREAKTHROUGH & TREATMENT: The new Alzheimer's drug aducanumabab (Aduhelm) has received accelerated approval by the US Food and Drug Administration. Why did it take so long to get there? Find out more.

Read more »

A Blood Test That Helps Detect Alzheimer's

DIAGNOSIS:

The PrecivityAD™ blood test accurately and reliably detected brain amyloid on a single blood sample. Intended for people with memory and thinking issues, the test was granted Breakthrough Device Designation by the FDA.

Read more »

Chinese Teen Invents Wearable Forget-Me-Not for Grandma

CAREGIVING & DESIGN: A young Chinese prodigy determined to help his grandmother with Alzheimer's invented an AI mini-computer to help her recognize family members and find the way home. Find out more.

Read more »

Discovery of Biomarker Could Predict Alzheimer's in Blood Test

DIAGNOSIS: A certain protein in the blood can be used to predict the eventual appearance of Alzheimer's. Will this allow for early intervention?

Read more »

Metformin Improves Cognitive Health in Type 2 Diabetes

Researchers studying Australians with type 2 diabetes found those taking the first-line treatment medication metformin had significantly slower cognitive decline compared to those who did not. Learn more.

Read more »

FDA Grants Priority Review to Aducanumab, Biogen's New Alzheimer's Treatment

MEDICATION TRIALS: The FDA has accepted Biogen's application for aducanumab, an investigational treatment for Alzheimer's, and even granted it Priority Review, with an action date set for March 7, 2021. Learn more.

Read more »

Female Chromosomes Offer Resilience to Alzheimer's

GENETICS & ALZHEIMER'S:

Women's second "X" chromosome provides them with more longevity, and researchers are finding they also have extra protection against Alzheimer's as well, through a special protective protein. Find out more.

Read more »